Literature DB >> 19058778

Anterior lamellar keratoplasty over penetrating keratoplasty for optical, therapeutic, and tectonic indications: a case series.

Marcus Ang1, Jodhbir S Mehta, Anshu Arundhati, Donald T H Tan.   

Abstract

PURPOSE: To report a consecutive case series of patients who underwent anterior lamellar keratoplasty (ALK) over a preexisting penetrating keratoplasty (PK).
DESIGN: Retrospective, interventional case series.
METHODS: Eight patients (8 eyes) were identified from the Singapore Corneal Transplant Study database, in a single institution (Singapore National Eye Center) from patients who underwent ALK performed over a PK. Main outcome measures were final visual acuity (VA), graft failure (ALK, PK or both), successful restoration of tectonic integrity in tectonic indications, and eradication of infection in therapeutic cases.
RESULTS: The indications for surgery were therapeutic in 3 patients, optical in 3 patients, and tectonic in 2 patients. Postoperatively the best-corrected visual acuity (BCVA) improved in 5 eyes and remained unchanged in 3 eyes. Mean VA improved significantly after ALK; the mean preoperative BCVA was 1.52 +/- 0.25 and the mean postoperative BCVA was 0.87 +/- 0.26 (P = .032). Three of the 8 eyes post-lamellar keratoplasty (LK) managed to attain a BCVA equal to post-PK BCVA. Two patients had suture micro-perforations while 1 patient required a repeat ALK for recurrence of infection.
CONCLUSION: ALK may be a considered as a viable alternative to a repeat PK for a variety of optical, therapeutic, and tectonic indications.

Entities:  

Mesh:

Year:  2008        PMID: 19058778     DOI: 10.1016/j.ajo.2008.10.002

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  Therapeutic penetrating keratoplasty for infectious and non-infectious corneal ulcers.

Authors:  Zuleyha Yalniz-Akkaya; Ayse Burcu; Emine Doğan; Mustafa Onat; Firdevs Ornek
Journal:  Int Ophthalmol       Date:  2014-03-21       Impact factor: 2.031

2.  Serial optical coherence tomography angiography for corneal vascularization.

Authors:  Yijun Cai; Jorge L Alio Del Barrio; Mark R Wilkins; Marcus Ang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-08       Impact factor: 3.117

3.  Development of Selective Lamellar Keratoplasty within an Asian Corneal Transplant Program: The Singapore Corneal Transplant Study (An American Ophthalmological Society Thesis).

Authors:  Donald Tan; Marcus Ang; Anshu Arundhati; Wei-Boon Khor
Journal:  Trans Am Ophthalmol Soc       Date:  2015

Review 4.  Post-keratoplasty Infectious Keratitis: Epidemiology, Risk Factors, Management, and Outcomes.

Authors:  Anna Song; Rashmi Deshmukh; Haotian Lin; Marcus Ang; Jodhbir S Mehta; James Chodosh; Dalia G Said; Harminder S Dua; Darren S J Ting
Journal:  Front Med (Lausanne)       Date:  2021-07-07

5.  Tectonic deep anterior lamellar keratoplasty in impending corneal perforation using cryopreserved cornea.

Authors:  Ji Hye Jang; Sung Dong Chang
Journal:  Korean J Ophthalmol       Date:  2011-03-11

6.  Differences in Surgical Management of Corneal Perforations, Measured over Six Years.

Authors:  Katarzyna Krysik; Dariusz Dobrowolski; Anita Lyssek-Boron; Judyta Jankowska-Szmul; Edward A Wylegala
Journal:  J Ophthalmol       Date:  2017-02-23       Impact factor: 1.909

7.  Novel application of In Vivo Micro-Optical Coherence Tomography to assess Cornea scarring in an Animal Model.

Authors:  Marcus Ang; Kavya Devarajan; Suchandrima Das; Gary H F Yam; Hla Mynt Htoon; Si Chen; Xinyu Liu; Linbo Liu; Michael Girard; Jodhbir S Mehta
Journal:  Sci Rep       Date:  2018-07-31       Impact factor: 4.379

8.  Case of isolated Rhizobium radiobacter contact lens-related infectious keratitis: A plant microbe now emerging as a human pathogen.

Authors:  Beau J Fenner; Ashish Kumar; Nicholas Y Q Tan; Marcus Ang
Journal:  Am J Ophthalmol Case Rep       Date:  2019-05-30

Review 9.  Management of corneal perforations: An update.

Authors:  Rashmi Deshmukh; Louis J Stevenson; Rasik Vajpayee
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.